10-24584927-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_020824.4(ARHGAP21):c.5362G>A(p.Val1788Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000279 in 1,613,950 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V1788L) has been classified as Uncertain significance.
Frequency
Consequence
NM_020824.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ARHGAP21 | NM_020824.4 | c.5362G>A | p.Val1788Met | missense_variant | 26/26 | ENST00000396432.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ARHGAP21 | ENST00000396432.7 | c.5362G>A | p.Val1788Met | missense_variant | 26/26 | 1 | NM_020824.4 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152176Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000719 AC: 18AN: 250404Hom.: 0 AF XY: 0.0000886 AC XY: 12AN XY: 135416
GnomAD4 exome AF: 0.0000287 AC: 42AN: 1461656Hom.: 0 Cov.: 33 AF XY: 0.0000358 AC XY: 26AN XY: 727138
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152294Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74466
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 03, 2022 | The c.5362G>A (p.V1788M) alteration is located in exon 26 (coding exon 25) of the ARHGAP21 gene. This alteration results from a G to A substitution at nucleotide position 5362, causing the valine (V) at amino acid position 1788 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at